title: Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment.
abstract: The specificity of autoantibodies against the serotoninergic 5-HT4 receptor in congenital heart block has led to conflicting observations. In order to clarify the situation, a collaborative effort was undertaken to discover the reasons for these discrepancies and to reassess the importance of such autoantibodies by making use of the Research Registry for Neonatal Lupus. Sera from 128 patients (101 anti-SSA/Ro52 positive mothers among which 74 have children with congenital heart block (CHB), 9 anti-SSA/Ro52 negative patients of which 1 had a child with heart block and 18 healthy donors) were assessed in a single blind test using an ELISA coated with a 5-HT4 receptor-derived peptide. Discrepancies between previous observations in our two groups could be ascribed to small differences in the set up of the assay. Of the 75 sera from mothers of children with CHB, 12 were reactive with the 5-HT4 peptide. Four sera among which three were from 35 Ro52 negative mothers without affected children as well as 2 in the 18 controls were positive. Interestingly, in 1 mother with an isolated child with CHB but who had no detectable anti-SSA/Ro52 antibodies and 1 mother with a child with a structural heart block and no detectable antibodies to any component of SSA/Ro, reactivity with the 5-HT4 receptor was noted. While 5-HT4 receptor autoantibodies do not have the predictive value of anti-Ro52 autoantibodies, the presence of these antibodies in a minor subset of mothers whose children have CHB suggests an additional risk factor which may contribute to the pathogenesis of disease.
authors: UPR9021 du C.N.R.S Immunologie et Chimie Thérapeutiques, I.B.M.C., F-67084 Strasbourg, France.
authors: Rehab
authors: R
authors: Kamel
authors: Pierre
authors: P
authors: Eftekhari
authors: Robert
authors: R
authors: Clancy
authors: Jill P
authors: JP
authors: Buyon
authors: Johan
authors: J
authors: Hoebeke
mesh_terms: D000595:Amino Acid Sequence; D001323:Autoantibodies / Q000096:biosynthesis*; D001327:Autoimmune Diseases / Q000097:blood / Q000151:congenital* / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006327:Heart Block / Q000097:blood / Q000151:congenital* / Q000276:immunology*; D006801:Humans; D008969:Molecular Sequence Data; D044422:Receptors, Serotonin, 5-HT4 / Q000276:immunology*; D012261:Ribonucleoproteins / Q000276:immunology; D000099207:SS-A Antigen
chemical_list: D001323:Autoantibodies; D044422:Receptors, Serotonin, 5-HT4; D012261:Ribonucleoproteins; D000099207:SS-A Antigen